Transcriptional activation in eukaryotes is often accompanied by alterations to chromatin structure at specific regulatory sites while other genomic regions may remain unchanged. In this study, we have examined the correlation between expression and chromatin accessibility of the human CR2 gene in a panel of cell lines (U937, REH, Ramos and Raji) using the CHART-PCR assay with the accessibility agent micrococcal nuclease (MNase). To validate the use of this assay for comparing multiple cell types, we first tested a series of genomic regions to determine if we could observe consistent, site specific levels of MNase chromatin accessibility.
Introduction
There are a variety of techniques that examine site specific chromatin structure and involve treating isolated chromatin or cell nuclei with a digestion agent and assessing resulting genomic DNA digestion patterns [1, 2] . More recently, an assay using realtime PCR to measure chromatin accessibility (CHART-PCR) was developed to define specific regions which are subject to chromatin structural variation during induction of gene expression [3] . It is clear that the accessibility of genomic DNA both within chromatin and to nuclear factors is highly regulated to control gene expression.
We are interested in understanding the molecular processes underling B-cell restricted expression of the human Complement receptor type 2 (CR2) gene. On B-cells, CR2
forms the BCR co-receptor complex together with CD19, CD81 and Leu13 [4] and can lower the threshold of antigen necessary for activation [5] . Expression of human CR2 is restricted during B-cell development and is observed on newly formed immature and mature B cells, initiated at approximately the same stage as IgD and CD23. In contrast, CR2 is undetectable during early stages of development (including pro-B cells and pre-B cells in the bone marrow) and upon terminal differentiation into antibody secreting plasma cells [6, 7] . Stringent regulation of CR2 on B-cells provides a model system of differentiation regulated transcription.
Presently, there are no physiologically relevant in vitro cell culture models available for initiating expression of the human CR2 gene. In this study, we used a panel of cell lines representing CR2 non-expressing (U937, REH) and CR2 expressing (Ramos, Raji) cell types to examine the correlation between accessibility of the CR2 core 4 promoter and transcriptional activation. To verify the utility of CHART-PCR for analysing multiple cell types we first compared the level of accessibility at a series of regulatory locations to determine if the assay produced comparable site-specific chromatin accessibility among the cell lines examined. To this end, we targeted promoter regions of both broadly expressed (β-actin and GAPDH) and developmentally restricted (PAX-7 and SP-A2) gene loci. PAX-7 encodes a transcription factor (TF) predominantly expressed during embryonic development and in adult myogenic precursor cells [8] , while SP-A2 encodes a cell surface receptor expressed at high level in human lungs and on some other epithelial cell types [9, 10] .
Our results demonstrate consistent, site specific chromatin digestion by MNase over these regulatory regions, which supports the efficacy of CHART-PCR assays for comparing chromatin accessibility between cell types.
Our laboratory has discovered several functional regulatory elements involved in cell type-specific repression and basal activation of human CR2 [11] [12] [13] . Now, having demonstrated the applicability of CHART-PCR for quantifying variation in accessibility in different cell types, we were able to apply this assay to examine the CR2 core promoter using the panel of cell lines representing CR2-expressing B-cells or non-expressing cell types. Our analyses showed enhanced chromatin accessibility in CR2-expressing cell lines (Ramos, Raji), while highly inaccessible chromatin was observed flanking the transcription start site (TSS) in non-expressing cell lines (U937, Reh). Sequence analysis of these regions of the CR2 core promoter revealed several TF consensus binding sites which could play a role in generating chromatin modifications or alternatively may become accessible to bind TFs as a result of the change in chromatin structure.
Materials and methods

Cell culture
Cell cultures were maintained at 37 o C with 5% CO 2 in RPMI-1640 supplemented with 10% FCS, 50 U/ml penicillin, 50 µg/ml streptomycin and 4 mM L-Glutamine.
Cell lines were obtained from the ATCC (Manassas, VA (Table 1, CR2-E2/3 and ß-actin) to amplify cDNA or serially diluted plasmid DNA. Relative CR2 levels were normalised to β-actin using the Quantitative Method (Rotor-Gene TM software v6.1).
Flow cytometry
Cell surface expression of CR2 was assessed as described previously [14] using banti-hCR2 (mAB171) or an isotype matched control (MOPC-21; BD Biosciences PharMingen, San Diego, CA) followed by secondary staining with phycoerythrin (PE)-conjugated streptavidin (BD Biosciences PharMingen). Stained cells were analyzed using the FACSCanto™ II flow cytometer (BD Biosciences PharMingen).
Data was collected with the FACSDiva™ software (BD Biosciences PharMingen) and processed using FlowJo v7.2.1 (TreeStar, Inc., San Carlos, CA).
CHART-PCR
Chromatin accessibility assays were performed as described previously with minor modifications [3] . Approximately 1.25 × 10 6 nuclei in 100 µl digestion buffer ( (+MNase) and "Uncut" (no MNase) samples using a series of primer pairs (Table 1) .
Chromatin accessibility ratios were calculated using the Rotor-Gene TM software v6.1,
Comparative Quantitation method to determine the ratio of "Uncut"/"Cut" from pairs of samples from independent accessibility reactions.
Bioinformatic analyses
Mouse and human sequence alignment was performed using CLC Combined Workbench Version 3.02 (CLC bio A/S, Cambridge, MA) with the online Clustal W program [15] . Consensus TF binding sites were identified using the online search tool, MatInspector (Genomatix Software GmbH, Munich, Germany). Predicted TSS motifs were detected using the online Eponine Transcription Start Site finder [16] .
Statistical analyses
Two-way ANOVA and Bonferroni post-test analyses were used to determine statistically relevant differences in chromatin accessibility among cell lines for each genomic region examined. All values described in the text represent the mean ± S.E.M. Statistics and graphs were generated with GraphPad Prism v4 (GraphPad Software, San Diego CA).
Results
CR2 mRNA levels correlate with cell-surface expression
CR2 expression levels were examined in cell lines by measuring relative transcript abundance using quantitative RT-PCR and cell surface density using flow cytometry.
We found clear differences in CR2 transcript levels and cell surface expression when comparing U937, REH, Ramos and Raji cells (Fig. 1A, B) . CR2 was undetectable at both the transcript and surface levels in U937 and REH cells (Fig. 1A, B) suggesting that the CR2 gene is transcriptionally silenced in these cells. In contrast, analysis of mature B-cell lines, Ramos and Raji revealed distinct CR2 expression patterns.
Ramos cells were bimodal for CR2 surface expression (Fig. 1B) and CR2 mRNA could readily be detected by Q-PCR (Fig. 1A) , while Raji cells comprise a population of cells expressing high surface levels of CR2 and expressing high levels (27-fold greater than Ramos) of CR2 mRNA ( Fig. 1 ) possibly reflecting differences in transcriptional activity of the CR2 gene.
Uniform chromatin digestion across all cell lines in CHART-PCR assays
To confirm that the previously described CHART-PCR assay [3] was a valid method to examine multiple cell types, MNase digestion patterns were compared in each of the cell lines. Electrophoresis of genomic DNA from MNase treated samples showed similar periodic banding patterns commonly observed in partially MNase digested chromatin ( Fig. 2A) consistently low levels of chromatin accessibility (Fig. 2B) . Sequences near the TSS of the constitutively active β-actin (-239 to -62 [19] ) and GAPDH (-217 to -68 [20] ) genes showed enhanced MNase chromatin accessibility compared to the regulatory regions of either PAX-7 or SP-A2 (Fig. 2B ) in all cell lines examined. Mean chromatin accessibility ratios were observed within the range of 3.56±0.18 (Fig. 2B, U937 ) and 6.05±0.40 (Fig. 2B, REH) for β-actin sequences and within the range of 4.19±028 (Fig. 2B , Ramos) and 9.36±0.94 (Fig. 2B, REH) for GAPDH sequences. These experiments demonstrate that, when using MNase as the digestion agent, CHART-PCR assays detect site specific variation in chromatin accessibility in a manner that is reproducible in multiple cell lines. Also, this data implies that CHART-PCR assays can detect subtle differences in chromatin accessibility at developmentally restricted gene loci.
Enhanced MNase accessibility within the -289 to -12 region of the human CR2 proximal promoter in CR2 expressing cells
Following verification of the utility of the CHART-PCR assay in assessing chromatin variation in different cell types, we then analysed changes across the CR2 gene promoter using cell lines representing different stages of B-cell ontogeny. Nonexpressing cell types were highly resistant to MNase digestion over the -115 to -12 region of the CR2 proximal promoter with accessibility ratios approaching one ( compared to each of the other cell lines examined ( Fig. 2A) . The level of chromatin accessibility across the -289 to -101 region was similar in Raji (3.60±0.13) and Ramos (3.06±0.50) cell lines (Fig. 3, p>0 .05). In contrast, the level of chromatin accessibility across the -115 to -12 region was significantly higher in Raji cells 
Sequence analysis of the CR2 core promoter
Since distinct differences in chromatin accessibility were observed within the CR2 proximal promoter we wished to analyse these regions to identify candidate sites which may bind TFs that could generate or respond to chromatin structural alterations. Aligning the human CR2 core promoter with corresponding mouse sequences revealed 61% identity. Consensus binding sites for several TFs were common to both human and mouse sequences including Sp-family members, CBF-1, CREB, C/EBP-β, BLIMP-1 as well as several E-box motifs (Fig. 4) , several of which are known to be involved in regulating chromatin structure or function in response to changes in chromatin structure.
Discussion
Previous studies examining chromatin structure during gene induction have shown that activation may be accompanied by increased chromatin accessibility at specific regulatory sites while other genomic regions remain unchanged. This has been observed at 5' flanking sequences of the TSS of E-selectin during endothelial cell activation [21] and also of GM-CSF [22] , IL-2 [23] and IL-10 [24] genes during T-cell activation. Since dynamic in vitro models for developmental initiation of human CR2 expression have not been described, the studies presented here utilised cell lines representing expressing and non-expressing cell types. To determine if CHART-PCR assays could reasonably be used to compare several cell lines we first examined chromatin accessibility at promoter regions chosen to represent constitutively active or developmentally restricted genomic sites. These analyses revealed a range of accessibility states at different genomic regions from highly inaccessible sequences at the PAX-7 promoter to highly accessible sequences at the GAPDH and β-actin promoters. The SP-A2 promoter region showed consistent intermediate chromatin accessibility ratios suggesting that this region was a suitable target to monitor chromatin digestion in the haematopoietic cell types examined. Therefore, when using MNase as an accessibility agent, CHART-PCR reveals site specific differences in chromatin accessibility that can be detected across several cell lines.
Previously, we have demonstrated that CR2 transcription is regulated by a cell typespecific repressor element within the proximal promoter designated E-box site 2 [11] .
Here we show that this repressor element is located within a region which is highly of the probability of productive transcription rather than the rate of transcription.
However, we can not rule out the possibility that chromatin accessibility within this region is graded to control transcription levels.
In addition to the highly protected segment flanking the CR2 TSS, non-expressing cell types showed significantly lower levels of MNase accessibility over the -289 to -101 region of the CR2 proximal promoter compared to CR2 expressing cell types. Since the sequence between -315 to +75 relative to the TSS comprises the minimal sequence necessary to drive basal activity of reporter constructs [13] , the results presented above suggest that extensive regions of the core promoter of the human CR2 gene are subject to chromatin structural alterations to regulate gene expression.
Transgenic mouse studies suggest that the precise timing of CR2 transcription activation during B-cell development is important for generating a robust, healthy Bcell repertoire [25, 26] . Presently, the signalling cues and transcription factors driving The human minimal core promoter sequence (Hs) is numbered relative to the major TSS (dotted arrow denotes +1) as previously described [13, 27] and aligned to the murine promoter sequence (Mm) [28] . Potential TSS motifs detected using the online Eponine Transcription Start Site finder are denoted (bold). Core consensus TF binding sites identified using MatInspector (Genomatix Software GmbH) which were common to both human and mouse sequence in addition to canonical E-box motifs (CANNTG) are shown in bold or underlined. Solid arrows indicate the location of primers used in Q-PCR assays targeting the CR2 promoter.
